Sign inGet started

Torres S. Edward

Insider CIK 1552293 · GBIM Director · PTGX 10% owner · ALRN · RCPT Director, 10% owner · SURF 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SURF Surface Oncology, Inc. C Conversion deriv2018-04-232018-04-237,000,000— $00SEC↗
SURF Surface Oncology, Inc. P Buy2018-04-232018-04-23266,000$15.00 $3.99M3,447,817SEC↗
SURF Surface Oncology, Inc. C Conversion2018-04-232018-04-233,181,817— $03,181,817SEC↗
ALRN AILERON THERAPEUTICS INC C Conversion deriv2017-07-052017-07-071,654,411— $00SEC↗
ALRN AILERON THERAPEUTICS INC C Conversion deriv2017-07-052017-07-071,443,972— $00SEC↗
ALRN AILERON THERAPEUTICS INC C Conversion deriv2017-07-052017-07-071,907,373— $00SEC↗
ALRN AILERON THERAPEUTICS INC C Conversion deriv2017-07-052017-07-073,390,885— $00SEC↗
ALRN AILERON THERAPEUTICS INC P Buy2017-07-052017-07-07250,000$15.00 $3.75M1,094,987SEC↗
ALRN AILERON THERAPEUTICS INC C Conversion2017-07-052017-07-07844,987— $0844,987SEC↗
PTGX Protagonist Therapeutics, C Conversion deriv2016-08-162016-08-163,000,000— $00SEC↗
PTGX Protagonist Therapeutics, C Conversion deriv2016-08-162016-08-169,142,857— $00SEC↗
PTGX Protagonist Therapeutics, C Conversion deriv2016-08-162016-08-169,841,333— $00SEC↗
PTGX Protagonist Therapeutics, C Conversion2016-08-162016-08-16630,541— $0837,437SEC↗
PTGX Protagonist Therapeutics, C Conversion2016-08-162016-08-16206,896— $0206,896SEC↗
PTGX Protagonist Therapeutics, P Buy2016-08-162016-08-16583,333$12.00 $7.00M2,099,482SEC↗
PTGX Protagonist Therapeutics, C Conversion2016-08-162016-08-16678,712— $01,516,149SEC↗
GBIM GLOBEIMMUNE INC S Sale2016-03-172016-03-2126,188$1.67 $43.7K241,706SEC↗
RCPT Receptos, Inc. D To issuer deriv2015-08-272015-08-279,400$204.56 $1.92M0SEC↗
RCPT Receptos, Inc. D To issuer deriv2015-08-272015-08-2718,800$213.23 $4.01M0SEC↗
RCPT Receptos, Inc. D To issuer2015-08-272015-08-277,400— $00SEC↗
RCPT Receptos, Inc. U Tender2015-08-252015-08-27665,561— $00SEC↗
GBIM GLOBEIMMUNE INC A Award deriv2015-07-092015-07-131,697— $01,697SEC↗
RCPT Receptos, Inc. S Sale2015-06-162015-06-1650,400$182.89 $9.22M665,561SEC↗
RCPT Receptos, Inc. S Sale2015-06-152015-06-1688,400$175.54 $15.52M715,961SEC↗
RCPT Receptos, Inc. S Sale2015-06-122015-06-1681,200$180.33 $14.64M804,361SEC↗
RCPT Receptos, Inc. A Award2015-05-282015-06-017,400— $07,400SEC↗
RCPT Receptos, Inc. S Sale2015-02-272015-03-037,200$130.15 $937.1K885,561SEC↗
RCPT Receptos, Inc. S Sale2015-02-232015-02-2425,953$130.54 $3.39M919,161SEC↗
RCPT Receptos, Inc. S Sale2015-02-232015-02-2526,400$129.95 $3.43M892,761SEC↗
RCPT Receptos, Inc. S Sale2015-02-202015-02-2421,953$125.43 $2.75M945,114SEC↗
RCPT Receptos, Inc. S Sale2014-09-232014-09-2485,682$61.07 $5.23M967,067SEC↗
RCPT Receptos, Inc. S Sale2014-09-222014-09-2414,318$63.08 $903.2K1,052,749SEC↗
RCPT Receptos, Inc. S Sale2014-09-192014-09-19169,570$62.55 $10.61M1,067,067SEC↗
RCPT Receptos, Inc. S Sale2014-09-182014-09-1991,513$62.77 $5.74M1,236,637SEC↗
RCPT Receptos, Inc. S Sale2014-09-172014-09-1938,917$63.67 $2.48M1,328,150SEC↗
RCPT Receptos, Inc. S Sale2014-08-132014-08-15200,000$43.24 $8.65M1,367,067SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-091,685,796— $00SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-09318,411— $00SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-093,736,921— $00SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-0950,684$1.45 $73.5K0SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-091,614— $01,614SEC↗
GBIM GLOBEIMMUNE INC C Conversion deriv2014-07-082014-07-151,614— $01,614SEC↗
GBIM GLOBEIMMUNE INC P Buy2014-07-082014-07-0985,000$10.00 $850.0K267,894SEC↗
GBIM GLOBEIMMUNE INC C Conversion2014-07-082014-07-09182,894— $0182,894SEC↗
RCPT Receptos, Inc. A Award deriv2014-06-032014-06-059,400— $09,400SEC↗
RCPT Receptos, Inc. S Sale2014-05-212014-05-2155,065$25.33 $1.39M1,567,067SEC↗
RCPT Receptos, Inc. S Sale2014-05-202014-05-21344,935$25.18 $8.69M1,622,132SEC↗
RCPT Receptos, Inc. S Sale2014-05-192014-05-2124,068$26.25 $631.8K1,967,067SEC↗
RCPT Receptos, Inc. S Sale2014-05-152014-05-1626,075$26.32 $686.3K1,991,135SEC↗
RCPT Receptos, Inc. S Sale2014-05-142014-05-1664,000$27.80 $1.78M2,017,210SEC↗
RCPT Receptos, Inc. A Award deriv2013-07-172013-07-1918,800— $018,800SEC↗
RCPT Receptos, Inc. C Conversion deriv2013-05-142013-11-210— $00SEC↗
RCPT Receptos, Inc. C Conversion deriv2013-05-142013-11-210— $00SEC↗
RCPT Receptos, Inc. P Buy2013-05-142013-11-21142,857$14.00 $2.00M2,081,210SEC↗
RCPT Receptos, Inc. C Conversion2013-05-142013-11-211,152,039$5.25 $6.05M1,266,324SEC↗
RCPT Receptos, Inc. C Conversion2013-05-142013-11-21672,029$7.73 $5.19M1,938,353SEC↗
RCPT Receptos, Inc. C Conversion deriv2013-05-142013-05-145,040,221— $00SEC↗
RCPT Receptos, Inc. C Conversion deriv2013-05-142013-05-148,640,289— $00SEC↗
RCPT Receptos, Inc. C Conversion2013-05-142013-05-14672,029$7.73 $5.19M1,938,353SEC↗
RCPT Receptos, Inc. C Conversion2013-05-142013-05-141,152,039$5.25 $6.05M1,266,324SEC↗
RCPT Receptos, Inc. P Buy2013-05-142013-05-14142,857$14.00 $2.00M2,081,210SEC↗